Literature DB >> 12622706

Comparison of outcomes of three different surgical techniques performed for stress urinary incontinence.

Hakan Kilicarslan1, Tevfik Guvenal, Semih Ayan, Gokhan Gokce, Ali Cetin, E Yener Gultekin.   

Abstract

BACKGROUND: The aim was to compare the efficacy of Burch colposuspension, transvaginal four-corner bladder neck suspension (FCBNS) and the vaginal wall sling (VWS) procedures in patients with stress urinary incontinence.
METHODS: A retrospective analysis was performed on 88 patients who underwent Burch colposuspension (n = 20), FCBNS (n = 29) and VWS (n = 39) for stress urinary incontinence. Objective and subjective cure rates at 3 months and annually after the operation were the primary outcome measures.
RESULTS: The patients were similar in age, parity, menopausal status, grade of cystocel and preoperative residual urine volumes. Fourteen out of 20 (70%) patients showed improvement in the group undergoing Burch colposuspension, 29 out of 39 (74.4%) patients showed improvement in the FCBNS group, and 28 out of 29 (96.6%) patients showed improvement in the VWS group. The mean length of follow up was 3.8 years (range 3-5).
CONCLUSION: In this study, the VWS procedure had a higher long-term cure rate of stress urinary incontinence when compared with the Burch colposuspension and the FCBNS procedures.

Entities:  

Mesh:

Year:  2003        PMID: 12622706     DOI: 10.1046/j.1442-2042.2003.00596.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  2 in total

Review 1.  Surgical treatment of pelvic organ prolapse: a historical review with emphasis on the anterior compartment.

Authors:  E J M Lensen; M I J Withagen; K B Kluivers; A L Milani; M E Vierhout
Journal:  Int Urogynecol J       Date:  2013-03-15       Impact factor: 2.894

Review 2.  Female stress urinary incontinence and the mid-urethral sling: is obstruction necessary to achieve dryness?

Authors:  Amy D Dobberfuhl; Elise J B De
Journal:  World J Urol       Date:  2015-05-30       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.